| Product Name | MF | CAS | Details |
|---|
| NLRP3-IN-17 | C21H22N4O2S | 2254432-75-0 | Details |
| RET-IN-22 | C29H31F3N6O4 | 2918281-79-3 | Details |
| CK2-IN-9 | C23H29N9O | 1461658-58-1 | Details |
| Antileishmanial agent-14 | 1638956-72-5 | Details |
| SIKs-IN-1 | C27H31F2N7O | 2927557-06-8 | Details |
| SHP2-IN-5 | C12H8O6 | 54755-93-0 | Details |
| Anticancer agent 164 | C21H23F3N8O2S2 | 2235393-30-1 | Details |
| Leramistat | C20H21ClN2O3S | 1642602-54-7 | Details |
| MuRF1-IN-2 | C23H22N2O7 | 937891-74-2 | Details |
| LTB4 antagonist 3 | C29H27NO6 | 2929239-87-0 | Details |
| Dim16 | C29H38IN5 | 2743448-32-8 | Details |
| AMX12006 | C26H22F3N3O3 | 2639775-01-0 | Details |
| (R)-Azasetron besylate | C17H20ClN3O3.C6H6O3S | 2025360-91-0 | Details |
| Erythronic acid | C4H8O5 | 13752-84-6 | Details |
| hnNOS-IN-2 | C18H23F2N3 | 2700326-00-5 | Details |
| Cholesterol nervonate | C51H90O2 | 60758-73-8 | Details |
| JNJ-1013 | C46H55N9O7S | 2597343-08-1 | Details |
| Pomalidomide-5-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2863635-00-9 | Details |
| Thalidomide-NH-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2460022-53-9 | Details |
| ZINC475239213 | C21H15N5O2 | 2871002-89-8 | Details |
| SRI 6409-94 | C24H29NO3 | 127697-58-9 | Details |
| ATR-IN-23 | C20H22N6O3S2 | 2923800-62-6 | Details |
| S-F24 | C25H27BrF2N6O | 2946669-78-7 | Details |
| Antitubercular agent-37 | C22H22N8O2 | 21696-12-8 | Details |
| NNRTIs-IN-1 | C28H22N6O3 | 2925364-09-4 | Details |
| HIV-1 protease-IN-8 | C25H35N3O5S | 2925287-55-2 | Details |
| Quorum Sensing-IN-2 | C19H13F2NO3 | 2925926-80-1 | Details |
| AJH-836 | C22H38O5 | 388621-67-8 | Details |
| Chitin synthase inhibitor 14 | C25H26ClN5O5 | 2922114-19-8 | Details |
| HPK1-IN-35 | C30H32N8O3S | 2935903-77-6 | Details |
| SHP2-IN-13 | C16H21N7O | 2951854-02-5 | Details |
| Neuraminidase-IN-13 | 2222067-23-2 | Details |
| Yhhu6669 | C29H28ClFN6O3 | 2569526-80-1 | Details |
| NS2B/NS3-IN-3 hydrochloride | C19H21N3O2.ClH | 2832876-91-0 | Details |
| MmpL3-IN-3 | C26H33ClN2Si | 1639438-67-7 | Details |
| EGFR-IN-82 | C32H41BrN9O2P | 2568086-81-5 | Details |
| Lepzacitinib | C18H21N5O3 | 2321488-47-3 | Details |
| CYP11A1-IN-1 | C27H34N2O5 | 2744168-51-0 | Details |
| EGFR-IN-85 | C26H30N8O2 | 1956378-29-2 | Details |
| M62812 free base | C13H11N3OS | 613262-61-6 | Details |
| IL-1β-IN-2 | 2242896-76-8 | Details |
| Nrf2 activator-7 | 2456295-39-7 | Details |
| TH-Z835 | C30H38N6O | 2766209-50-9 | Details |
| Smurf1-IN-1 | C24H29ClN6O2 | 1824708-03-3 | Details |
| MMP13-IN-4 | C21H17BrN4O5 | 514855-02-8 | Details |
| BChE/HDAC6-IN-1 | C34H43N5O5 | 2925457-27-6 | Details |
| MY-673 | C18H14N2O4 | 2944459-96-3 | Details |
| SIRT5 inhibitor 7 | C28H32ClN7O3S | 2951090-00-7 | Details |
| HDAC-IN-63 | C25H26Cl2N6O3 | 2920046-95-1 | Details |
| YIAD-0205 | C26H16Br2ClN3 | 2446054-34-6 | Details |
| SIRT5 inhibitor 6 | C21H28N6O4S | 2834736-82-0 | Details |
| BRD4 Inhibitor-28 | C23H21N3O3 | 2468960-80-5 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| Anticancer agent 110 | C18H13FN6OS | 887349-03-3 | Details |
| NLRP3-IN-21 | C20H13Cl2F3N6O2S | 2956791-61-8 | Details |
| Keap1-Nrf2-IN-15 | 2456295-45-5 | Details |
| MAO-B-IN-23 | C19H18BrNO | 2107978-22-1 | Details |
| EP12 | C26H22FN3O2 | 2882916-73-4 | Details |
| BC-05 | C21H29BN2O9 | 2260717-73-3 | Details |
| U-89843A | C16H24ClN5 | 157013-85-9 | Details |
| Aβ/tau aggregation-IN-3 | C23H22N4O3 | 1210750-32-5 | Details |
| S07-1066 | C16H11Cl2FO2 | 876625-29-5 | Details |
| J-1048 | C23H17FN6S2 | 2374772-60-6 | Details |
| Antimalarial agent 26 | C20H22N4O3 | 2299199-56-5 | Details |
| HDAC-IN-58 | C16H13ClF2N4O3S | 2071224-39-8 | Details |
| HIF-2α-IN-9 | C12H13F5O4S2 | 2648334-36-3 | Details |
| SDH-IN-5 | C16H19F2N3O2 | 2922765-95-3 | Details |
| Antimalarial agent 24 | C20H16N4O2 | 2299199-54-3 | Details |
| LSD1-UM-109 | C29H27FN6 | 2252446-26-5 | Details |
| Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 | C30H58N10O12 | 2244602-35-3 | Details |
| Ac-Exatecan | C26H24FN3O5 | 2922852-48-8 | Details |
| MC-VA-PAB-Exatecan | C50H54FN7O11 | 2680543-57-9 | Details |
| SJ1461 | C21H18ClN7OS2 | 2924546-70-1 | Details |
| Ilaprazole sodium hydrate | C19H21N4NaO3S | 2322264-11-7 | Details |
| SLC26A3-IN-3 | C20H17IO5 | 2369983-43-5 | Details |
| IDO1-IN-21 | 2892432-98-1 | Details |
| E235 | C28H25FN4OS | 891894-69-2 | Details |
| Aurora Kinases-IN-4 | C26H28N8O | 2877011-84-0 | Details |
| CS640 | C21H31N7O | 2388506-83-8 | Details |
| A-77636 | C20H27NO3 | 778546-51-3 | Details |
| (R)-VX-11e | C24H20Cl2FN5O2 | 1680187-43-2 | Details |
| α-Synuclein inhibitor 9 | C27H24O4 | 1510825-03-2 | Details |
| TWIK-1/TREK-1-IN-2 | C20H29F3N2O2 | 1440532-32-0 | Details |
| TWIK-1/TREK-1-IN-1 | C21H24F3NO3 | 1440532-30-8 | Details |
| Z-LLF-CHO | C29H39N3O5 | 133429-58-0 | Details |
| Anti-amyloid agent-1 | C21H17F3N2O3 | 1396778-73-6 | Details |
| Dihydro-5-azacytidine acetate | 2470972-18-8 | Details |
| PDE7-IN-3 | C18H21ClN2O4 | 908570-13-8 | Details |
| PU-48 | C14H12N2O3S | 335394-78-0 | Details |
| OPC-163493 | C14H8F3N5S | 1644467-84-4 | Details |
| Xilmenolone | C26H37N3O2 | 2368807-26-3 | Details |
| CDK/HDAC-IN-3 | C24H18Cl2N6O3 | 2944087-54-9 | Details |
| Tubulin inhibitor 33 | C24H22N4O3 | 2944462-67-1 | Details |
| GBT1118 | C19H20N2O4 | 1628799-51-8 | Details |
| BODIPY FL thalidomide | C37H43BF2N6O7 | 2740620-18-0 | Details |
| DNA gyrase B-IN-3 | C14H9Cl2N3O4S | 2412834-56-9 | Details |
| SARS-CoV-2 nsp14-IN-3 | C17H17N3O3S | 2920574-16-7 | Details |
| LTB4 antagonist 2 | C26H23NO6 | 2929239-85-8 | Details |
| HIV-1 inhibitor-57 | C25H24FN5O3S | 2745197-24-2 | Details |
| Product Total： Product Page： | ||||
| 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | ||||